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Abstract
Pulmonary papillary adenoma is a very rare tumor usually presenting in periphery of the lung. Herein, we present a
case of pulmonary papillary adenoma located in central portion of the lung in a 17 year-old Chinese female.
A well-defined mass was incidentally detected at right pulmonary hilar region by imaging examination. Histologically,
the tumor is predominantly composed of abundant papillary structures lined by columnar to cuboidal epithelial cells
resembling type II pneumocytes. Immunohistochemical staining showed that the epithelial cells were diffusely positive
for cytokeratin, cytokeratin7, TTF-1, EMA, surfactant apoprotein A, Napsin A, P63 and β-catenin. The Ki-67 proliferation
index was approximately 2 %. Based on morphologic features and the immunohistochemical profile, the tumor was
consistent with pulmonary papillary adenoma. Thus, it should be noted that pulmonary papillary adenoma was also a
possible diagnosis for a central mass.
Keywords: Pulmonary papillary adenoma, Lung tumor
Background
Pulmonary papillary adenoma is a very rare tumor that first
described by Fantone et al. in 1982 [1]. So far, less than 25
cases were reported in the English literature [2–16]. The
reported cases predominatly occurred in periphery of the
lung. In contrast, we present a case of pulmonary papillary
adenoma located in the central portion of the lung in a
17 year-old Chinese female. This tumor was generally con-
sidered benign; however, some scientists thought that it
might have malignant potential because of its microinvasive
characteristics [9, 10]. The patient was alive with no evi-




A 17-year-old female without a history of smoking was
admitted to our hospital for complaining of a right pul-
monary nodule incidentally detected during routine
examination. The patient was asymptomatic; physical
examination and routine laboratory studies were all
within normal values. X-ray demonstrated that there was
a well-defined solid mass measuring 3.13 cm in the diam-
eter at the right pulmonary hilar region (Fig.1). In the
current visit, the patient underwent wedge resection in
our hospital. The postoperative course was uneventful,
and there was no evidence of disease 12 months later.
Materials and methods
The resected specimens were fixed with 10 % neutral-
buffered formalin and embedded in paraffin blocks.
Tissue blocks were cut into 4-μm slides, deparaffinized
in xylene, rehydrated with graded alcohols, and immu-
nostained with the following antibodies: cytokeratin
(CK), cytokeratin7(CK7), CD68, Vimentin, thyroid tran-
scription factor 1 (TTF-1), epithelial membrane antigen
(EMA), surfactant apoprotein A (SPA), Napsin A, synap-
tohysin, CD56, P63 and β-catenin, p53 and Ki-67. Sections
were stained with a streptavidin-peroxidase system
(KIT-9720, Ultrasensitive TM S-P, MaiXin, China). The
chromogen used was diaminobenzidine tetrahydrochloride
substrate (DAB kit, MaiXin, China), slightly counterstained
with hematoxylin, dehydrated and mounted. For the
negative controls, the primary antibody was replaced with
PBS. This study was prospectively performed and approved
by the institutional Ethics Committees of China Medical
University and conducted in accordance with the ethical
guidelines of the Declaration of Helsinki.
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Grossly, the mass was approximately 3.0 × 2.9 × 2.6 cm, and
was relatively well circumscribed. The cut face was firm
and grey-white or grey-yellow in color (Fig.2a).
Histologic features
Histologically, the tumor was relatively well defined, and
there was a fibrous capsule around the tumor. The capsule
infiltration, normal lung tissue, vessels and pleura invasion
was not present in the tumor (Fig.2b). The tumor was
predominantly composed of papillary structures with fibro-
vascular cores (Fig.2c). Focally, the abundant hyalinized
collagen with few cells was present in the core of the papil-
lary structure reminiscent of sclerostic pattern of sclerosing
pneumocytoma. Contrastly, the stroma of papillary struc-
ture lacked the polygnonal cells presenting in sclerosing
pneumocytoma (Fig.2d).
The lining cells on the papillary pattern were columnar
or cuboidal with mild atypia, clear cytoplasm, fine chroma-
tin and inconspicuous or small nucleoli. The numerous
nuclear inclusions were present in the epithelial cells. The
mitosis of the cells is very rare (Fig.2f). However, focally,
the cells showed florid hyperplasia, and form the micropa-
pillary or irregular cribriform pattern, which might pose a
diagnostic challenge. In addition, abundant histiocytes
were present in the spaces of the tumor (Fig.2e).
Immunohistochemical staining and molecular detection
Immunohistochemical staining showed that the lining cells
were diffusely positive for TTF-1, EMA, CK, CK7, SPA,
P63 and Napsin A, and negative for vimentin, synaptophy-
sin and CD56. The epithelial cells also showed a strong
membranous staining for β-catenin. In addition, the cells
of the stroma were negative for TTF-1, β-catenin and
EMA, indicating the lack of epithelial differentiation. CD68
Fig. 1 The X-ray manifestation of the tumor. ab, The tumor was relatively well circumscribed, located in the hilar region of the right lung
Fig. 2 Morphological change of the tumor. a, Grossly, the mass was well circumscribed, with a firm and grey-white cut face. b, The tumor was
encapusuled by the fibrous capsule. c, The tumor was composed predominantly of papillary structures with fibrovascular cores. d, The abundant
hyalinized collagen with few cells was focally present in the core of the papillary structure. e, Numerous histiocytes was present in the outer spaces of
papillary structures, which might cause a diagnostic confusion. f, The lining cells were columnar or cuboidal with mild atypia and extremely rare mitosis,
and numerous nuclear inclusions
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staining highlighted the presence of histiocytes in the
tumor. Few cells showed a weak P53 staining. Ki-67 was
expressed in less than 2 % of all tumor cells (Fig. 3).
According to the morphological and immunohistochemical
findings, the tumor was consistent with papillary adenoma.
We then examined the EGFR and K-ras gene muta-
tions, and failed to find the mutations in this tumor.
Discussion
Pulmonary papillary adenoma is a very rare tumor. So far,
fewer than 25 cases were reported in the English literature
[1–16]. In 1980, Spencer et al. reviewed 19 cases of papil-
lary, non-invasive tumors arising from the bronchial epithe-
lium, of which two cases were described as Clara cell origin
[2]. In 1982, Fantone et al. used the term papillary adenoma
to describe the tumor showing type 2 pneumocytes or
Clara cells differentiation, as the presence of cytoplasmic
dense granules and whorled lamellar membrane inclusions
in the cells [1]. Subsequently, approximately 20 cases were
reported [3–16]. Of them, the majority showed type 2
pneumocytes differentiation. Thus, papillary adenoma was
believed to be derived from primitive mutipotential respira-
tory epithelium with bidirectional differentiation [3, 7–10].
Histologically, the tumor comprised by the papillary
structures with fibrovascular stroma. The lining cells
were usually single layer, cuboidal to columnar. In our
case, the cells focally showed florid hyperplasia, formed
the micropapillary, sheets or irregular cribriform pattern.
This might post a great challenge, especially during the
frozen section diagnosis. In addition, it was noted that
the numerous nuclear inclusions were present in the
epithelial cells, which was commonly present in tumors
showing type 2 pneumocytes differentiation [17, 18].
If the tumor showed type 2 pneumocytes differentiation,
the cells ultrastructurally contained lamellar bodies and
positive for surfactant apoprotein antigen; where staining
positively for a Clara cell-specific antigen indicated the
differentiation towards Clara cell. The present case was
Fig. 3 Immunohistochemical staining of the tumor. a, b, c, The lining cells were strongly positive for CK, CK7 and EMA respectively. d, The constant and
strong membranous staining for β-catenin was seen in the tumor cells. e, Ki-67 proliferative index was less than 2 %. f, The CD68 staining highlighted
the presence of histiocytes. g, the cells were diffusely positive for SPA. h, Scattered cells showed a weak staining for P53. i, the cells were also diffusely
positive for P63. j, Napsin A was strongly and diffusely expressed in the tumor cells. k, TTF-1was positively expressed in the lining cells in contrast to the
negative expression in the cells of the stroma. l, Vimentin was expressed in the stroma rather than the lining cells
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diffusely positive for SPA, indicating the tumor mainly
differentiated towards type 2 pneumocytes. Immunohisto-
chemically, the neoplastic cells also showed reactivity for
TTF-1, EMA, CK and CK7 [15]. In addition to the above
markers, our case was also positive for Napsin A, a useful
marker for type II pneumocytes [19]. Surprisingly, in the
present case, the cells also demonstrated diffusely reactiv-
ity for P63. P63 was mainly expressed in squamous cells,
rarely expressed in pneumocytes. It is unclear the signifi-
cance of diffuse P63 expression in our case.
According to the literature review from Kristine et al.,
papillary adenoma predominatly occurred in periphery
of the lung [15]. In the contrast, our present case was lo-
cated in the hilar portion of the lung. Although papillary
adenoma was thought as a peripheral lesion, it should be
noted that this tumor maybe a diagnosis as to the mass
located in the hilar area.
It was still debated about the clinical behavior of this
tumor. The neoplastic cells were usually lacked marked
atypia, high mitosis rate and Ki-67 proliferation rate.
Thus, it was generally considered benign; however, some
authors advocated that it might have malignant potential
because of the infiltration into the capsule, into the adja-
cent lung parenchyma or visceral pleura. In our case, the
tumor was relatively well encapsuled and there was no
evidence of capsule, normal lung tissue, vessels and
pleura invasion. The patient was alive with no evidence
of tumor recurrence or metastasis within 12 months of
follow-up. Nevertheless, the longer follow–up was still
necessary, as the potential relationship between papillary
adenoma and adenocarcinoma [9].
The differential diagnosis of the tumor includes pulmon-
ary sclerosing pneumocytoma, alveolar adenoma, atypical
adenomatous hyperplasia, and papillary adenocarcinoma.
Pulmonary sclerosing pneumocytoma is a relatively rare
but distinctive tumor [20, 21]. The immunohistochemical
and molecular findings have strongly documented that
pulmonary sclerosing pneumocytoma also originates from
primitive respiratory epithelium [22]. Thus, pulmonary
sclerosing pneumocytoma may have the same origin with
papillary adenoma. It is characterized by two cell types,
namely surface cuboidal cells and polygonal cells located
in the stroma of the papillary structures. The presence of
polygonal cells in pulmonary sclerosing pneumocytoma,
which also showed positivity for TTF-1, was a peculiar fea-
ture for differential diagnosis. Additionally, in the present
case, the cells showed strong and constant membran-
ous staining for β-catenin, which was consistent with
the staining pattern in cuboidal cells of pulmonary scleros-
ing pneumocytoma, indicating their common origin [21].
Alveolar adenoma is characterized by multiple cystic
spaces lined by single layer of flat to cuboidal to type II
pneumocytes containing a granular material. The cysts
are often filled with an eosinophilic proteinaceous fluid.
The widespread presence of papillary morphology could
aid in excluding this tumor. Atypical adenomatous
hyperplasia is a small (usually ≤0.5 cm) preinvasive lesion.
It is characterized by proliferation of mildly to moderately
type II pneumocytes with lepidic pattern along the alveo-
lar walls. The presence of broad papillary structures could
also distinguish the papillary adenoma from atypical aden-
omatous hyperplasia. Moreover, the lack of cellular atypia
and mitosis could exclude papillary adenocarcinoma. The
gene mutations of EGFR and K-ras could be involved in
pulmonary adenocarcinoma, which was well documented
[23]. The absence of EGFR and K-ras gene mutations in
papillary adenoma might also be helpful for differential
diagnosis.
Conclusion
Pulmonary papillary adenoma is an extremely rare tumor
characterized by widespread papillary structures. The re-
ported cases predominatly occurred at the periphery,
nevertheless, we presented the case located in central por-
tion of the lung, indicating it should still be considered for
a central mass.
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